Abstract
Objective: NAD+ is a co-factor and substrate for enzymes maintaining energy homeostasis. Nicotinamide phosphoribosyltransferase (NAMPT) controls NAD+ synthesis, and in skeletal muscle, NAD+ is essential for muscle integrity. However, the underlying molecular mechanisms by which NAD+ synthesis affects muscle health remain poorly understood. Thus, the objective of the current study was to delineate the role of NAMPT-mediated NAD+ biosynthesis in skeletal muscle development and function. Methods: To determine the role of Nampt in muscle development and function, we generated skeletal muscle-specific Nampt KO (SMNKO) mice. We performed a comprehensive phenotypic characterization of the SMNKO mice, including metabolic measurements, histological examinations, and RNA sequencing analyses of skeletal muscle from SMNKO mice and WT littermates. Results: SMNKO mice were smaller, with phenotypic changes in skeletal muscle, including reduced fiber area and increased number of centralized nuclei. The majority of SMNKO mice died prematurely. Transcriptomic analysis identified that the gene encoding the mitochondrial permeability transition pore (mPTP) regulator Cyclophilin D (Ppif) was upregulated in skeletal muscle of SMNKO mice from 2 weeks of age, with associated increased sensitivity of mitochondria to the Ca2+-stimulated mPTP opening. Treatment of SMNKO mice with the Cyclophilin D inhibitor, Cyclosporine A, increased membrane integrity, decreased the number of centralized nuclei, and increased survival. Conclusions: Our study demonstrates that NAMPT is crucial for maintaining cellular Ca2+ homeostasis and skeletal muscle development, which is vital for juvenile survival.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 101271 |
Tidsskrift | Molecular Metabolism |
Vol/bind | 53 |
ISSN | 2212-8778 |
DOI | |
Status | Udgivet - nov. 2021 |
Bibliografisk note
Funding Information:Support for this study was provided by the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) . CBMR is an independent Research Center at the University of Copenhagen that is partially funded by an unrestricted donation from the Novo Nordisk Foundation ( NNF18CC0034900 ). This study was also funded by separate grants from the Novo Nordisk Foundation (Excellence Project Award NNF14OC0009315 to JTT and Challenge Grant NNF14OC0011493 to Juleen R. Zierath) from the Danish Council for Independent Research (Research Project Grant DFF 4004-00235 to JTT and DFF 5053-00195 to JF), and from the European Foundation for the Study of Diabetes (EFSD/Lilly Research Fellowship to JTT).